Latest Asx News

Simble Solutions reported steady cash flow and operational growth in Q4 FY25, alongside a strategic acquisition and capital raise to bolster its energy intelligence offerings.

Tasman Resources reports a robust cash position and a valuable stake in Eden Innovations, while gearing up for significant drilling programs at its South Australian projects in 2026.

dorsaVi has launched a multi-year collaboration with leading Asian research institutes to develop its proprietary RRAM technology at the 22-nanometer node, targeting AI-driven robotics and wearable applications.

Koba Resources has reported remarkably high tin assay results up to 26.1% from initial rock chip sampling at its Stannary Hills Tin-Tungsten Project in Queensland, setting the stage for a maiden drilling campaign in early 2026.

Great Southern Mining's recent aircore drilling at the Mon Ami Gold Project in Western Australia has revealed promising gold intercepts, suggesting potential extensions to the existing resource and new parallel lodes.

Aurelia Metals announces Managing Director Bryan Quinn will resign by July 2026, with a leadership search underway amid key project developments.

Southern Cross Gold Consolidated Ltd has reported exceptional drill results from its Sunday Gold-Antimony Creek Project in Victoria, revealing a large, continuous high-grade gold-antimony deposit with strategic critical mineral value.

American Uranium Limited has reported significant progress at its Lo Herma ISR uranium project, completing extensive drilling and validating aquifer conditions that support in-situ recovery mining. The company is poised to update its resource estimates and advance development plans in 2026.

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.

Regener8 Resources has completed its first phase of Ultrafine™ soil sampling at the North Achilles project in NSW, revealing promising precious and base metal anomalies along major fault zones. The company is planning further sampling and geophysical surveys to advance towards drilling.

EV Resources has reported impressive high-grade assays from its Milton Antimony Project in Nevada, revealing significant antimony, copper, and silver mineralisation and setting the stage for detailed follow-up exploration.

Patrys Limited has acquired Reliis, gaining a promising injectable formulation of quetiapine aimed at treating delirium with a rapid FDA approval pathway. This move positions Patrys at the forefront of addressing a significant unmet medical need in critical care.